Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bayer
Company Monitoring Page for Bayer
latest headlines for company on cafepharma
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Mon, 08/28/23 - 11:37 am
Tags:
Bayer
,
Parkinson's Disease
,
cell therapy
,
bemdaneprocel
,
BlueRock Therapeutics
Bayer's digital drive in consumer health gathers pace
Pharmaphorum
Wed, 08/23/23 - 10:08 am
Tags:
Bayer
,
consumer health
,
digital health
,
Mahana Therapeutics
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Fierce Pharma
Thu, 08/17/23 - 11:35 pm
Tags:
Bayer
,
Hawaii
,
Maui
,
wildfires
,
donations
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Fierce Biotech
Thu, 08/17/23 - 11:32 pm
Tags:
BlueRock Therapeutics
,
Parkinson's Disease
,
Bayer
,
layoffs
With sales in free fall, Bayer's new CEO Anderson considers structural change
Fierce Pharma
Tue, 08/8/23 - 10:34 pm
Tags:
Bayer
,
Pharma CEOs
,
Bill Anderson
Bayer ends respiratory distress drug development in latest phase 2 cleanout
Fierce Pharma
Tue, 08/8/23 - 10:21 am
Tags:
Bayer
,
adrenomedullin pegol
,
earnings
,
ARDS
Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case
Fierce Pharma
Tue, 07/25/23 - 11:56 am
Tags:
Bayer
,
earnings
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
Tags:
TV ads
,
DTC advertising
,
Bayer
,
AbbVie
,
Bristol Myers Squibb
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Fierce Biotech
Wed, 06/28/23 - 10:05 am
Tags:
Bayer
,
Parkinson's Disease
,
clinical trials
,
cell therapy
,
bemdaneprocel
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Mon, 06/12/23 - 11:22 pm
Tags:
Bayer
,
oncology
,
M&A
Bayer licenses lipid nanoparticle tech for gene therapy
BioProcess International
Wed, 06/7/23 - 10:17 am
Tags:
Bayer
,
Acuitas Therapeutics
,
gene editing
Bayer launches precision health unit in latest digital health venture
BioPharma Dive
Fri, 06/2/23 - 10:12 am
Tags:
Bayer
,
consumer health
,
digital health
,
precision health
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Thu, 06/1/23 - 06:43 pm
Tags:
Bayer
,
Cedilla Therapeutics
,
CyclinE1/CDK2 inhibitors
,
oncology
,
precision oncology
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Fierce Biotech
Wed, 05/24/23 - 10:23 am
Tags:
Bayer
,
business development
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Tags:
Astellas
,
Iveric Bio
,
Bayer
,
Amgen
,
M&A
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
BioSpace
Wed, 05/10/23 - 10:04 am
Tags:
Bayer
,
Bicycle Therapeutics
,
drug development
,
radiopharmaceuticals
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen
,
Regeneron Pharmaceuticals
,
Sanofi
,
Supreme Court
,
patents
,
Pfizer
,
Bayer
,
Roche
,
Genentech
,
AstraZeneca
,
JNJ
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D
,
Amgen
,
Bayer
,
Biogen
,
Gilead Sciences
,
Merck KGaA
,
Moderna Therapeutics
,
Novo Nordisk
,
Regeneron Pharmaceuticals
,
UCB
,
Vertex Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.